These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24036369)

  • 1. Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway.
    Zhang Y; Hai J; Cao M; Zhang Y; Pei S; Wang J; Zhang Q
    Int Immunopharmacol; 2013 Nov; 17(3):714-20. PubMed ID: 24036369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
    Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
    Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition.
    Li HB; Yang YR; Mo ZJ; Ding Y; Jiang WJ
    Braz J Med Biol Res; 2015 May; 48(5):440-6. PubMed ID: 25760026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats.
    Zhang Q; Tan Y; Zhang N; Yao F
    Mol Med Rep; 2015 Jan; 11(1):603-10. PubMed ID: 25333896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
    Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.
    Hong X; Tang H; Wu L; Li L
    J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats.
    Li Y; Wang J; Gu T; Yamahara J; Li Y
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):155-63. PubMed ID: 24704288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
    Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
    Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
    Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
    Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
    Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d- chiro-Inositol Ameliorates High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance via PKCε-PI3K/AKT Pathway.
    Cheng F; Han L; Xiao Y; Pan C; Li Y; Ge X; Zhang Y; Yan S; Wang M
    J Agric Food Chem; 2019 May; 67(21):5957-5967. PubMed ID: 31066268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.
    Li L; Yao Y; Zhao J; Cao J; Ma H
    Int J Obes (Lond); 2020 May; 44(5):1075-1086. PubMed ID: 31911660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of rutin on liver injury in type 2 diabetic db/db mice.
    Liang W; Zhang D; Kang J; Meng X; Yang J; Yang L; Xue N; Gao Q; Han S; Gou X
    Biomed Pharmacother; 2018 Nov; 107():721-728. PubMed ID: 30138894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis.
    Xu H; Zhou Y; Liu Y; Ping J; Shou Q; Chen F; Ruo R
    J Endocrinol; 2016 May; 229(2):133-44. PubMed ID: 26941037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
    Li S; Wang X; Zhang J; Li J; Liu X; Ma Y; Han C; Zhang L; Zheng L
    Braz J Med Biol Res; 2018; 51(8):e7299. PubMed ID: 29924135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.